Innovation and Investments in Diagnostics: Discussing Patents & the Future of Laboratory Test Inventions

Patenting novel and inventive clinical laboratory tests has become one of the most consequential topics in diagnostics today. At the center of the debate is a fundamental question facing laboratory owners, innovators, investors, and policymakers alike:

Do patents protect innovation in diagnostics and encourage investment, or do they risk limiting access, competition, and patient care?

This webinar brings together laboratory leaders with firsthand experience developing, scaling, and defending novel diagnostic technologies to explore both sides of the conversation. Through a moderated, fireside-style discussion, panelists will examine how intellectual property policy intersects with innovation, competition, and real-world laboratory operations.

The conversation will feature brief spotlights on emerging diagnostic innovations, followed by a broader discussion on the evolving patent landscape, including the proposed Patent Eligibility Restoration Act, and what this movement could mean for the future of laboratory medicine.

What Attendees Will Gain:

• Insight into how patent eligibility impacts diagnostic innovation, funding, and commercialization
• Perspectives on the potential downstream effects on laboratories, patients, and competition
• A look at some of the newest innovations in diagnostics and laboratory medicine
• A nuanced, live discussion on one of the most important policy issues shaping the future of laboratory medicine
• Advice on how you can help impact the trajectory of the PERA legislation